SoftBank Group Corp. will sell its chip designer Arm, a vital supplier to Apple Inc., to Nvidia Corp. for as much as $40 billion.
Nvidia will pay SoftBank $12 billion in cash and $21.5 billion in shares.
SoftBank and the Vision Fund, which has a 25 percent stake in Arm, will take a stake in Nvidia of between 6.7 and 8.1 percent.
Brisk business performance could earn SoftBank an additional $5 billion in cash or Nvidia shares and Arm employees $1.5 billion in shares.
SoftBank CEO Masayoshi Son had been praising Arm for its potential but has since been slashing his stakes.
The sale marks an early exit for SoftBank in the British chip technology firm, just four years after its $32 billion acquisition.
The Arm acquisition puts vital suppliers across the industry under the control of Nvidia.
Arm licenses its chip designs and technology the likes of Qualcomm Inc, Apple, and Samsung Electronics Co. Ltd.
Forthcoming Mac computers are also slated to use chips from Arm.
Nvidia CEO Jensen Huang intends to retain Arm’s neutral licensing model and license out Nvidia's graphical processor unit through Arm’s silicon partners.
A new artificial intelligence research center will be built at Arm’s Cambridge headquarters.
With the acquisition, Nvidia anticipates more intense competition from data center chip rivals such as Advanced Micro Devices Inc. and Intel Corp.


Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
SK Hynix Shares Surge on Record $28.6 Billion Buyback
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
OpenAI Tightens AI Safety Monitoring After Security Incidents
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Standard Chartered Expands Hedge Fund Access for Wealth Clients
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 



